rg 12525 has been researched along with Asthma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kreft, AF; Musser, JH | 1 |
| Feiss, G; Nelson, HS; Paull, BR; Smith, JA; Tobey, RE; Welch, MJ | 1 |
| Hirose, K; Okawara, S; Sakakibara, H | 1 |
| Tattersfield, AE; Wahedna, I; Wisniewski, AS | 1 |
2 review(s) available for rg 12525 and Asthma
| Article | Year |
|---|---|
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines | 1992 |
[Peptidoleukotriene receptor antagonists in asthma therapy].
Topics: Asthma; Chromones; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Propionates; Quinolines; SRS-A; Sulfonamides; Tetrazoles; Tosyl Compounds | 1996 |
2 trial(s) available for rg 12525 and Asthma
| Article | Year |
|---|---|
Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adults.
Topics: Adolescent; Adult; Asthma; Double-Blind Method; Female; Humans; Leukotriene D4; Lung; Male; Patient Dropouts; Placebos; Quinolines; Respiratory Function Tests; Tetrazoles | 1994 |
Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Topics: Administration, Oral; Adolescent; Adult; Asthma; Bronchoconstriction; Double-Blind Method; Forced Expiratory Volume; Humans; Male; Middle Aged; Quinolines; SRS-A; Tetrazoles | 1991 |